Scarica l'app Stockscreener
154.30
3.14%
4.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$149.52
Aprire:
$157.03
Volume 24 ore:
715.42K
Relative Volume:
0.81
Capitalizzazione di mercato:
$8.69B
Reddito:
$633.51M
Utile/perdita netta:
$-8.10M
Rapporto P/E:
-497.74
EPS:
-0.31
Flusso di cassa netto:
$131.26M
1 W Prestazione:
+3.63%
1M Prestazione:
+28.78%
6M Prestazione:
+16.74%
1 anno Prestazione:
+11.61%
Intervallo 1D:
$152.44
$157.21
Intervallo di 1 settimana:
$143.47
$157.21
Portata 52W:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Confronta RGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
154.55 | 8.35B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
436.06 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
183.50 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.26 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.22 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
266.23 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Iniziato | HSBC Securities | Buy |
| 2025-09-22 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
Tools to monitor Repligen Corporation recovery probabilityJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
Oct 28 Webcast: Repligen to Report Third Quarter Results; Conference Call 8:30 a.m. ET - Stock Titan
Does Repligen Corporation stock trade at a discount to peersJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com
Technical signs of recovery in Repligen CorporationWeekly Risk Report & AI Forecasted Entry and Exit Points - newser.com
Earnings call transcript: Repligen Q2 2025 sees revenue growth, stock dips - Investing.com
Historical volatility pattern of Repligen Corporation visualizedIPO Watch & Expert Curated Trade Ideas - newser.com
Using data tools to time your Repligen Corporation exit2025 Technical Patterns & Weekly Momentum Picks - newser.com
Repligen Corporation (RGEN) Stock Analysis: An Investor’s Guide to a 23.4% Potential Upside - DirectorsTalk Interviews
Repligen (NASDAQ:RGEN) Rating Increased to Buy at Wall Street Zen - Defense World
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know - Barchart.com
Hollow Fiber Filtration Market Is Booming Worldwide 2025-2032 | - openPR.com
Repligen (RGEN) Receives a Hold from Guggenheim - The Globe and Mail
Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? - Insider Monkey
Repligen Corporation’s volatility index tracking explainedWall Street Watch & Verified Trade Idea Suggestions - newser.com
Can technical indicators confirm Repligen Corporation’s reversal - newser.com
Repligen Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Repligen’s SWOT analysis: bioprocessing leader faces growth challenges - Investing.com
Evercore ISI Issues Positive Forecast for Repligen (NASDAQ:RGEN) Stock Price - Defense World
RGEN: Evercore ISI Group Maintains "Outperform" Rating, Raises P - GuruFocus
Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175 - 富途牛牛
Repligen (RGEN): Assessing Valuation Following HSBC’s Positive Coverage and Renewed Biotech Optimism - simplywall.st
Short interest data insights for Repligen CorporationMarket Volume Report & Safe Entry Point Alerts - newser.com
Is Repligen Corporation stock affected by interest rate hikesGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
111 Capital Purchases New Holdings in Repligen Corporation $RGEN - MarketBeat
What indicators show strength in Repligen Corporation2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Can New Analyst Attention on RGEN Reveal the True Strength of Repligen's Bioprocessing Edge? - simplywall.st
Is Repligen’s Recent 18% Price Surge Justified After Broad Biotech Rally? - Yahoo Finance
Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) 28% Share Price Surge - simplywall.st
Why Repligen Corporation stock attracts global investorsMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Key metrics from Repligen Corporation’s quarterly dataWeekly Trade Report & Community Shared Stock Ideas - newser.com
Why Repligen Corporation stock is a must watch in 2025July 2025 Movers & Accurate Intraday Trading Signals - newser.com
Published on: 2025-10-03 00:54:45 - newser.com
Applying big data sentiment scoring on Repligen Corporation2025 Risk Factors & Reliable Breakout Forecasts - newser.com
GAMMA Investing LLC Sells 132 Shares of Repligen Corporation $RGEN - Defense World
Repligen (RGEN) Poised for Rebound Amid Market Shifts - GuruFocus
What 8 Analyst Ratings Have To Say About Repligen - Benzinga
Best Manufacturing Stocks To Follow TodayOctober 1st - MarketBeat
Repligen (RGEN) Receives "Buy" Rating from HSBC with Target Pric - GuruFocus
Why Is Repligen (RGEN) Stock Soaring Today - Yahoo Finance
Repligen (RGEN) Gains Momentum with HSBC's Buy Rating and Strong Growth Outlook - GuruFocus
HSBC initiates coverage on Repligen stock with Buy rating, $150 target - Investing.com
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know - Yahoo Finance
Fifth Third Bancorp Reduces Stock Position in Repligen Corporation $RGEN - Defense World
What analysts say about Repligen Corporation RGN stockGlobal Trade Effects & Free Popular Stock Picks Selection - earlytimes.in
Is Repligen Corporation (RGN) stock bottoming after sell offJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
How Repligen Corporation stock performs in interest rate cycles2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Repligen Corp Azioni (RGEN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
Sep 10 '25 |
Sale |
120.52 |
29,111 |
3,508,389 |
100,743 |
5.32%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):